Trovafloxacin Treatment of Viridans Group Streptococcus Experimental Endocarditis

The activity of trovafloxacin was compared with those of vancomycin and penicillin in a model of Streptococcus sanguis species group (trovafloxacin MIC, 0.125 μg/ml) and Streptococcus mitis species group (trovafloxacin MIC, 0.125 μg/ml) experimental endocarditis. Rabbits with catheter-induced aortic...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Piper, Kerryl E., Rouse, Mark S., Ronningen, Karen L., Steckelberg, James M., Wilson, Walter R., Patel, Robin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90106/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10952616/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.9.2554-2556.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!